Welcome to CDC stacks | A Potential Cellular Explanation for the Increased Risk of Clostridium difficile Infection Due to Hypoalbuminemia: A Response to Di Bella SD et al - 36222 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
A Potential Cellular Explanation for the Increased Risk of Clostridium difficile Infection Due to Hypoalbuminemia: A Response to Di Bella SD et al
  • Published Date:
    Oct 12 2015
  • Source:
    Infect Control Hosp Epidemiol. 36(12):1480.
Filetype[PDF-29.18 KB]


No Related Documents.
You May Also Like:
  1. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China
    Personal Author:
    Zhou, F. F.; Wu, S.; Klena, J. D.; Huang, H. H.;
    Published:
    May 13 2014
    Source:
    Eur J Clin Microbiol Infect Dis. 33(10):1773-1779.
    Description:
    The purpose of this study was to identify clinical characteristics of Clostridium difficile infection (CDI) in patients with antibiotic-associated diarrhea (AAD). A prospective study was conducted among patients hospitalized in Fudan University Hospi...
    File Type:
    Filetype[PDF - 327.96 KB]
  2. Predicting the Risk for Hospital-onset Clostridium difficile Infection (HO-CDI) at the Time of Inpatient Admission: HO-CDI Risk Score
    Personal Author:
    Tabak, Ying P.; Johannes, Richard S.; Sun, Xiaowu; Nunez, Carlos M.; McDonald, L. Clifford;
    Published:
    Mar 10 2015
    Source:
    Infect Control Hosp Epidemiol. 36(6):695-701.
    Description:
    Objective : To predict the likelihood of hospital-onset Clostridium difficile infection (HO-CDI) based on patient clinical presentations at admission : Design : Retrospective data analysis : Setting : Six US acute care hospitals : Patients : Adult in...
    File Type:
    Filetype[PDF - 547.55 KB]
  3. Clinical Risk Factors for Severe Clostridium difficile–associated Disease
    Personal Author:
    Henrich, Timothy J.; Krakower, Douglas; Bitton, Asaf; Yokoe, Deborah S.;
    Published:
    Mar 2009
    Source:
    Emerg Infect Dis. 15(3):415-422.
    Description:
    Identifying patients who are at high risk for severe Clostridium difficile-associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes. Therefore, we compared clinical features associated with severe versus n...
    File Type:
    Filetype[PDF - 227.76 KB]
  4. Proteomic Analysis and Label-Free Quantification of the Large Clostridium difficile Toxins
    Personal Author:
    Moura, Hercules; Terilli, Rebecca R.; Woolfitt, Adrian R.; Williamson, Yulanda M.; Wagner, Glauber; Blake, Thomas A.; Solano, Maria I.; Barr, John R.;
    Published:
    Aug 27 2013
    Source:
    Int J Proteomics. 2013; 2013.
    Description:
    Clostridium difficile is the leading cause of antibiotic-associated diarrhea in hospitals worldwide, due to hypervirulent epidemic strains with the ability to produce increased quantities of the large toxins TcdA and TcdB. Unfortunately, accurate qua...
    File Type:
    Filetype[PDF - 6.07 MB]
  5. A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile
    Personal Author:
    Donald, Robert G. K.; Flint, Mike; Kalyan, Narender; Johnson, Erik; Witko, Susan E.; Kotash, Cheryl; Zhao, Ping; Megati, Shakuntala; Yurgelonis, Irina; Lee, Phillip Kwok; Matsuka, Yury V.; Severina, Elena; Deatly, Anne; Sidhu, Mini; Jansen, Kathrin U.; Minton, Nigel P.; Anderson, Annaliesa S.;
    Published:
    Apr 29 2013
    Source:
    Microbiology. 159(Pt 7):1254-1266.
    Description:
    The Clostridium difficile toxins A and B are primarily responsible for symptoms of C. difficile associated disease and are prime targets for vaccine development. We describe a plasmid-based system for the production of genetically modified toxins in ...
    File Type:
    Filetype[PDF - 880.10 KB]